{"id":44052,"date":"2022-05-18T12:01:25","date_gmt":"2022-05-18T10:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/"},"modified":"2022-05-18T12:01:25","modified_gmt":"2022-05-18T10:01:25","slug":"dr-cheryl-renz-joins-pregistry-as-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/","title":{"rendered":"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer"},"content":{"rendered":"
\n

\nPregistry\u2019s Latest Recruitment Brings Senior Executive Talent to the Team<\/i>\n<\/p>\n

LOS ANGELES–(BUSINESS WIRE)–#CMO<\/a>—Pregistry<\/a>, a leader in the development and conduct of observational studies during pregnancy, announced today the appointment of Dr. Cheryl Renz as the company\u2019s Chief Medical Officer (CMO). In this role, Dr. Renz will oversee medical and pharmacovigilance strategies for the rapidly growing maternal health organization.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nDr. Cheryl Renz is an accomplished biopharmaceutical executive with expertise in clinical development, pharmacovigilance, and benefit-risk management. Most recently, she served as Head of Benefit Risk Management at AbbVie, where she led company-wide benefit-risk assessments, as well as the development and implementation of risk management strategies. She also directed pioneering digital health innovation initiatives. Previously, Dr. Renz successfully led global drug development programs across multiple therapeutic areas at Abbott, including virology, immunology, metabolics, respiratory, neuroscience, and pain. Her biopharmaceutical career was preceded by over 10 years of broad research experience involving both clinical and benchwork research.\n<\/p>\n

\nDr. Renz earned a Doctor of Medicine degree from the University of Chicago Pritzker School of Medicine, as well as Master’s and Bachelor’s degrees in Biochemistry from the University of Rochester. She completed a residency in Internal Medicine and fellowships in Clinical Pharmacology and Pulmonary and Critical Care Medicine at the University of Chicago Hospitals.\n<\/p>\n

\n\u201cWe are proud to welcome Dr. Cheryl Renz as a member of the Pregistry team. She will help ensure that Pregistry\u2019s study participants’ information is thoroughly reviewed for quality and properly medically assessed,\u201d said Dr. Diego Wyszynski, Pregistry CEO. \u201cAs we continue to expand the depth of our medical studies and the overall breadth of our work, Dr. Renz will ensure compliance with internal and external regulations, and work with our Scientific Advisory Committee members and pharmaceutical company representatives to set the strategy for future accomplishments.\u201d\n<\/p>\n

\nPregistry is a leader in the development and execution of post-approval studies that assess the safety of medications and vaccines used during pregnancy and lactation. Ongoing studies open for enrollment include the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER)<\/a> and the COVID-19 International Drug Pregnancy Registry (COVID-PR)<\/a>.\n<\/p>\n

\nAbout Pregistry<\/b>\n<\/p>\n

\nPregistry is a global leader in the development and conduct of observational studies to assess the safety of medications and vaccines when used during pregnancy. With over 70 pregnancy specialists, covering a range of clinical, preclinical, safety, regulatory, marketing, and IT needs, the focus is on making sure that both mother and baby are healthy and safe and that prescribers have the information needed to be able to explain the potential benefits and risks of medications during pregnancy. Pregistry also offers pregnant people a safe space to connect with a global community of experts and peers at no cost. To learn more, please visit: https:\/\/www.pregistry.com<\/a>. More Pregistry news can be found at Pregistry.com\/News<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nINVESTOR CONTACT<\/b>
Diego Wyszynski, MD, MHS, PhD – Chief Executive Officer
\n
hello@pregistry.com<\/a>\n<\/p>\n

\nMEDIA CONTACT<\/b>
Abigail Baker, MA – Director of Communications
\n
press@pregistry.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pregistry\u2019s Latest Recruitment Brings Senior Executive Talent to the Team LOS ANGELES–(BUSINESS WIRE)–#CMO—Pregistry, a leader in the development and conduct of observational studies during pregnancy, announced today the appointment of Dr. Cheryl Renz as the company\u2019s Chief Medical Officer (CMO). In this role, Dr. Renz will oversee medical and pharmacovigilance strategies for the rapidly growing … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44052","6":"format-standard","7":"category-industry"},"yoast_head":"\nDr. Cheryl Renz Joins Pregistry as Chief Medical Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Pregistry\u2019s Latest Recruitment Brings Senior Executive Talent to the Team LOS ANGELES–(BUSINESS WIRE)–#CMO—Pregistry, a leader in the development and conduct of observational studies during pregnancy, announced today the appointment of Dr. Cheryl Renz as the company\u2019s Chief Medical Officer (CMO). In this role, Dr. Renz will oversee medical and pharmacovigilance strategies for the rapidly growing ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-18T10:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220518005001\/en\/1441624\/21\/C_Renz_Headshot_Press_Release.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer\",\"datePublished\":\"2022-05-18T10:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/\"},\"wordCount\":504,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005001\\\/en\\\/1441624\\\/21\\\/C_Renz_Headshot_Press_Release.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/\",\"name\":\"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005001\\\/en\\\/1441624\\\/21\\\/C_Renz_Headshot_Press_Release.jpg\",\"datePublished\":\"2022-05-18T10:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005001\\\/en\\\/1441624\\\/21\\\/C_Renz_Headshot_Press_Release.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220518005001\\\/en\\\/1441624\\\/21\\\/C_Renz_Headshot_Press_Release.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer - Pharma Trend","og_description":"Pregistry\u2019s Latest Recruitment Brings Senior Executive Talent to the Team LOS ANGELES–(BUSINESS WIRE)–#CMO—Pregistry, a leader in the development and conduct of observational studies during pregnancy, announced today the appointment of Dr. Cheryl Renz as the company\u2019s Chief Medical Officer (CMO). In this role, Dr. Renz will oversee medical and pharmacovigilance strategies for the rapidly growing ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-18T10:01:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220518005001\/en\/1441624\/21\/C_Renz_Headshot_Press_Release.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer","datePublished":"2022-05-18T10:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/"},"wordCount":504,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518005001\/en\/1441624\/21\/C_Renz_Headshot_Press_Release.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/","url":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/","name":"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220518005001\/en\/1441624\/21\/C_Renz_Headshot_Press_Release.jpg","datePublished":"2022-05-18T10:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220518005001\/en\/1441624\/21\/C_Renz_Headshot_Press_Release.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220518005001\/en\/1441624\/21\/C_Renz_Headshot_Press_Release.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dr-cheryl-renz-joins-pregistry-as-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dr. Cheryl Renz Joins Pregistry as Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44052"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44052\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}